Mirion Technologies, Inc. (NYSE:MIR) Shares Bought by Chescapmanager LLC

Chescapmanager LLC grew its stake in Mirion Technologies, Inc. (NYSE:MIR - Free Report) by 27.5% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 1,327,895 shares of the company's stock after buying an additional 286,494 shares during the quarter. Mirion Technologies accounts for approximately 2.5% of Chescapmanager LLC's portfolio, making the stock its 13th biggest position. Chescapmanager LLC owned approximately 0.57% of Mirion Technologies worth $23,172,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in MIR. US Bancorp DE increased its position in Mirion Technologies by 3,248.7% during the fourth quarter. US Bancorp DE now owns 6,262 shares of the company's stock worth $109,000 after buying an additional 6,075 shares during the period. Tower Research Capital LLC TRC increased its position in Mirion Technologies by 162.9% during the fourth quarter. Tower Research Capital LLC TRC now owns 6,649 shares of the company's stock worth $116,000 after buying an additional 4,120 shares during the period. Harvest Fund Management Co. Ltd acquired a new position in Mirion Technologies during the fourth quarter worth approximately $120,000. KBC Group NV increased its position in Mirion Technologies by 39.2% during the fourth quarter. KBC Group NV now owns 8,002 shares of the company's stock worth $140,000 after buying an additional 2,254 shares during the period. Finally, Corient Private Wealth LLC acquired a new position in Mirion Technologies during the fourth quarter worth approximately $187,000. Hedge funds and other institutional investors own 78.51% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on the company. Citigroup dropped their target price on Mirion Technologies from $20.00 to $17.00 and set a "buy" rating on the stock in a report on Monday, April 14th. B. Riley dropped their target price on Mirion Technologies from $19.00 to $17.00 and set a "buy" rating on the stock in a report on Wednesday, April 16th. Finally, Robert W. Baird dropped their target price on Mirion Technologies from $22.00 to $20.00 and set an "outperform" rating on the stock in a report on Friday, April 4th. Four investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Buy" and a consensus target price of $18.75.

Mirion Technologies Trading Up 3.5%

NYSE:MIR traded up $0.60 on Tuesday, hitting $17.55. 712,893 shares of the stock were exchanged, compared to its average volume of 1,897,113. The stock has a market cap of $4.07 billion, a PE ratio of -92.37 and a beta of 0.74. The company has a current ratio of 2.16, a quick ratio of 1.55 and a debt-to-equity ratio of 0.43. The stock has a fifty day moving average of $14.65 and a 200-day moving average of $15.77. Mirion Technologies, Inc. has a fifty-two week low of $9.11 and a fifty-two week high of $18.81.

Mirion Technologies (NYSE:MIR - Get Free Report) last posted its earnings results on Tuesday, April 29th. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.08 by $0.02. Mirion Technologies had a positive return on equity of 4.78% and a negative net margin of 4.21%. The business had revenue of $202.00 million during the quarter, compared to analyst estimates of $199.34 million. During the same quarter last year, the firm earned $0.06 earnings per share. The company's revenue for the quarter was up 4.9% compared to the same quarter last year. As a group, equities analysts expect that Mirion Technologies, Inc. will post 0.39 earnings per share for the current fiscal year.

About Mirion Technologies

Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.